Several factors, including altered gene expression, insulin resistance, fatty liver disease, disrupted signaling pathways, and nutrient imbalances, may contribute to the nuanced relationship between obesity-related changes in metabolism, inflammatory processes, and the expression and activity of ALDH2. This evidence concerns the gene ALDH2 and fatty liver disease.